Back to User profile » Professor Giorgio Lorenzo Colombo

Papers published by Professor Giorgio Lorenzo Colombo:


Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus

Torre E, Colombo GL, Di Matteo S, Martinotti C, Valentino MC, Rebora A, Cecoli F, Monti E, Galimberti M, Di Bartolo P, Gaggioli G, Bruno GM

ClinicoEconomics and Outcomes Research 2021, 13:503-518

Published Date: 14 June 2021

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2020, 12:177-189

Published Date: 8 April 2020

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

Canonica GW, Colombo GL, Rogliani P, Santus P, Pitotti C, Di Matteo S, Martinotti C, Bruno GM

Risk Management and Healthcare Policy 2020, 13:43-53

Published Date: 22 January 2020

Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis

Migliore A, Integlia D, Pompilio G, Di Giuseppe F, Aru C, Brown T

ClinicoEconomics and Outcomes Research 2019, 11:453-464

Published Date: 22 July 2019

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2018, 10:413-421

Published Date: 26 July 2018

The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis

Colombo GL, Di Matteo S, Martinotti C, Oselin M, Bruno GM, Beghi GM

ClinicoEconomics and Outcomes Research 2018, 10:75-82

Published Date: 23 January 2018

Adherence in ulcerative colitis: an overview

Testa A, Castiglione F, Nardone OM, Colombo GL

Patient Preference and Adherence 2017, 11:297-303

Published Date: 22 February 2017

Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy

Poli A, Di Matteo S, Bruno GM, Fornai E, Valentino MC, Colombo GL

Risk Management and Healthcare Policy 2015, 8:207-213

Published Date: 18 November 2015

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

Colombo GL, Castagna A, Di Matteo S, Galli L, Bruno G, Poli A, Salpietro S, Carbone A, Lazzarin A

Therapeutics and Clinical Risk Management 2014, 10:9-15

Published Date: 18 December 2013

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

Aitini E, Rossi A, Morselli P, Vivorio B, Bruschi A, Bottura C, Colombo GL.

Cancer Management and Research 2012, 4:99-103

Published Date: 27 March 2012